RENAL CELL CARCINOMA

This is a first-in-human study to find a safe dose and understand how the body processes an experimental oral drug called ACC-1898. The drug aims to block proteins that help cancer cells grow and spread. The study will enroll about 40 adults with advanced solid tumors who have ru…

This study tests whether people with advanced kidney cancer can safely stop their immunotherapy drugs after doctors use targeted treatments to remove or destroy all visible tumors. Researchers want to see if patients can stay off cancer medications for at least 12 months without …

This early-stage study is testing a new type of personalized immune cell therapy called GCAR1 in people with advanced cancers that have stopped responding to standard treatments. The main goal is to find the safest and most effective dose of GCAR1 for patients with specific types…

This study is testing whether two experimental drugs, given alone or together before surgery, can safely shrink kidney tumors. The goal is to see if this pre-surgical treatment helps control the cancer. About 32 adults with a specific type of kidney cancer that can be surgically …

This research study aims to find new, non-invasive ways to classify kidney cancer and predict its spread. Researchers will analyze tiny particles in stored urine samples to identify cancer markers and will also check blood samples from patients before and after kidney removal sur…

This study aims to see if a new type of PET scan using a tracer called 82-Rb can accurately tell how aggressive a kidney cancer tumor is before a patient has surgery. Researchers will scan 50 patients with kidney cancer and compare the scan results to the final tumor analysis aft…